Anixa Biosciences IncNASDAQ:ANIX
- LAST PRICE2.9800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.0000/ 6
- Ask / Lots3.2200/ 2
- Open / Previous Close0.0000 / 2.9800
- Day Range---
- 52 Week Range
- Volume1,346
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ANIX |
|---|---|---|
| 09:32 ET | 4769 | 3.25 |
| 09:34 ET | 4131 | 3.24 |
| 09:36 ET | 200 | 3.21 |
| 09:38 ET | 2900 | 3.15 |
| 09:39 ET | 2530 | 3.133 |
| 09:43 ET | 2500 | 3.1574 |
| 09:45 ET | 1844 | 3.15 |
| 09:48 ET | 400 | 3.17 |
| 09:50 ET | 4700 | 3.1816 |
| 09:52 ET | 100 | 3.17 |
| 09:54 ET | 300 | 3.1689 |
| 09:57 ET | 215 | 3.17 |
| 10:01 ET | 3371 | 3.22 |
| 10:03 ET | 2969 | 3.2299 |
| 10:06 ET | 1614 | 3.235 |
| 10:08 ET | 4053 | 3.27 |
| 10:10 ET | 2400 | 3.23 |
| 10:12 ET | 405 | 3.23 |
| 10:14 ET | 400 | 3.23 |
| 10:17 ET | 155 | 3.2252 |
| 10:26 ET | 2750 | 3.2299 |
| 10:28 ET | 500 | 3.25 |
| 10:30 ET | 2554 | 3.24 |
| 10:32 ET | 300 | 3.2301 |
| 10:33 ET | 280 | 3.23 |
| 10:35 ET | 3000 | 3.245 |
| 10:37 ET | 100 | 3.24 |
| 10:42 ET | 200 | 3.24 |
| 10:48 ET | 2700 | 3.2575 |
| 10:50 ET | 1600 | 3.2545 |
| 10:53 ET | 610 | 3.26 |
| 10:55 ET | 400 | 3.2799 |
| 10:57 ET | 650 | 3.27 |
| 11:00 ET | 9018 | 3.32 |
| 11:04 ET | 600 | 3.285 |
| 11:08 ET | 4549 | 3.32 |
| 11:09 ET | 128 | 3.31 |
| 11:11 ET | 200 | 3.301 |
| 11:13 ET | 1489 | 3.3 |
| 11:15 ET | 2400 | 3.26 |
| 11:18 ET | 1205 | 3.2702 |
| 11:22 ET | 1000 | 3.2701 |
| 11:36 ET | 250 | 3.285 |
| 11:38 ET | 300 | 3.27 |
| 11:45 ET | 8564 | 3.2937 |
| 11:47 ET | 918 | 3.2701 |
| 11:49 ET | 100 | 3.2983 |
| 12:00 ET | 114 | 3.2837 |
| 12:02 ET | 750 | 3.24 |
| 12:07 ET | 2700 | 3.24 |
| 12:09 ET | 4299 | 3.2 |
| 12:12 ET | 150 | 3.2092 |
| 12:18 ET | 250 | 3.2399 |
| 12:23 ET | 300 | 3.18 |
| 12:30 ET | 200 | 3.1801 |
| 12:32 ET | 3082 | 3.11 |
| 12:34 ET | 370 | 3.13 |
| 12:52 ET | 211 | 3.1201 |
| 12:54 ET | 235 | 3.12 |
| 12:56 ET | 569 | 3.13 |
| 01:01 ET | 1536 | 3.1 |
| 01:03 ET | 233 | 3.11 |
| 01:06 ET | 6479 | 3.05 |
| 01:10 ET | 838 | 3.0392 |
| 01:12 ET | 1114 | 3.06 |
| 01:14 ET | 200 | 3.02 |
| 01:15 ET | 500 | 3.04 |
| 01:17 ET | 100 | 3.0298 |
| 01:19 ET | 1050 | 3.03 |
| 01:21 ET | 23916 | 2.9509 |
| 01:24 ET | 3300 | 2.948 |
| 01:26 ET | 2000 | 3 |
| 01:28 ET | 200 | 2.99 |
| 01:30 ET | 893 | 3.0013 |
| 01:32 ET | 800 | 2.99 |
| 01:33 ET | 3580 | 3.01 |
| 01:35 ET | 4407 | 2.99 |
| 01:37 ET | 1645 | 2.9937 |
| 01:39 ET | 200 | 3.02 |
| 01:44 ET | 490 | 3.01 |
| 01:46 ET | 2350 | 3.0399 |
| 01:48 ET | 100 | 3.04 |
| 01:50 ET | 280 | 3.05 |
| 01:51 ET | 400 | 3.07 |
| 01:53 ET | 2199 | 3.09 |
| 01:57 ET | 1529 | 3.1192 |
| 02:02 ET | 390 | 3.11 |
| 02:04 ET | 300 | 3.11 |
| 02:08 ET | 1000 | 3.1 |
| 02:09 ET | 1475 | 3.07 |
| 02:11 ET | 1100 | 3.08 |
| 02:13 ET | 390 | 3.0603 |
| 02:18 ET | 200 | 3.09 |
| 02:29 ET | 615 | 3.0743 |
| 02:31 ET | 3293 | 3.05 |
| 02:36 ET | 995 | 3.05 |
| 02:38 ET | 1200 | 3.05 |
| 02:49 ET | 290 | 3.05 |
| 02:54 ET | 100 | 3.07 |
| 02:56 ET | 100 | 3.055 |
| 02:58 ET | 200 | 3.07 |
| 03:07 ET | 500 | 3.07 |
| 03:09 ET | 100 | 3.07 |
| 03:18 ET | 200 | 3.07 |
| 03:20 ET | 500 | 3.06 |
| 03:21 ET | 1400 | 3.055 |
| 03:23 ET | 600 | 3.06 |
| 03:25 ET | 830 | 3.0501 |
| 03:27 ET | 3703 | 3.03 |
| 03:30 ET | 15114 | 2.98 |
| 03:34 ET | 3978 | 3.0399 |
| 03:36 ET | 300 | 3.03 |
| 03:38 ET | 2780 | 3.01 |
| 03:39 ET | 400 | 3.01 |
| 03:41 ET | 5247 | 3 |
| 03:43 ET | 5795 | 3 |
| 03:45 ET | 100 | 2.99 |
| 03:48 ET | 200 | 2.99 |
| 03:50 ET | 200 | 3.0199 |
| 03:52 ET | 179 | 2.9942 |
| 03:54 ET | 2700 | 2.9999 |
| 03:56 ET | 2431 | 2.98 |
| 03:57 ET | 100 | 2.99 |
| 03:59 ET | 2272 | 2.98 |
Apr 18, 2024
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board, from 8:20AM ET on Thursday Apr 18, 2024 by Dow Jones
8:20AM ET on Thursday Apr 18, 2024 by Dow JonesPress Release: Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board, from 8:20AM ET on Thursday Apr 18, 2024 by Dow Jones
8:20AM ET on Thursday Apr 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Anixa Biosciences Inc | 95.1M | -8.6x | --- |
Eliem Therapeutics Inc | 95.1M | -2.6x | --- |
IO Biotech Inc | 95.5M | -0.7x | --- |
DiaMedica Therapeutics Inc | 96.0M | -4.1x | --- |
Vigil Neuroscience Inc | 97.0M | -1.2x | --- |
Elicio Therapeutics Inc | 93.1M | -1.0x | --- |
Company Information
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.
Contact Information
- Headquarters
- 3150 Almaden Expy Ste 250SAN JOSE, CA, United States 95118
- Phone
- 408-708-9808
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Amit Kumar
- President, Chief Financial Officer, Chief Operating Officer, Company Secretary
- Michael Catelani
- Lead Independent Director
- Lewis Titterton
- Independent Director
- Arnold Baskies
- Independent Director
- Emily Gottschalk
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $95.1M |
|---|---|
Revenue (TTM) | $210.0K |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.87 |
EPS | $-0.35 |
Book Value | $0.78 |
P/E Ratio | -8.6x |
Price/Sales (TTM) | 452.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,744.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
